Table 1 Baseline characteristics of patients with Pneumocystis jirovecci pneumonia requiring mechanical ventilation in intensive care unit
Patient characteristics | N = 119 |
|---|---|
Median age, years | 65.0 (56.0–72.0) |
Sex (male) | 76 (63.9) |
Height, cm | 163.0 (156.0–170.0) |
BMI, kg/m2 | 22.3 (20.1–25.0) |
Ever smoker | 34 (28.6) |
Charlson Comorbidity Index | 3 (2–4) |
Comorbidity disease | |
 Congestive heart failure | 11 (9.2) |
 Coronary arterial disease | 21 (17.6) |
 Chronic lung disease—airway | 9 (7.6) |
 Chronic lung disease—ILD | 22 (18.5) |
 Chronic kidney disease | 31 (26.1) |
 Chronic liver disease | 9 (7.6) |
 Cerebrovascular disease | 4 (3.4) |
 Solid cancer | 37 (31.1) |
 Hematologic malignancy | 22 (18.5) |
 Immunosuppressive agent use | 27 (22.7) |
CRRT due to AKI | 41 (34.5) |
APACHE II score | 26.5 (20.0–32.0) |
SOFA score | 8 (6–11) |
SAPS II | 37.0 (29.0–18.8) |
Cytomegalovirus antigenemia | 75 (63.0) |
Clinical parameters | |
 WBC, × 103/μL | 10.2 (5.9–15.3) |
 Platelet, × 103/μL | 132.5 (60.8–246.0) |
 BUN, mg/dL | 29.5 (19.5–44.6) |
 Creatinine, mg/dL | 1.07 (0.62–1.90) |
 Albumin, g/dL | 2.5 (2.2–2.7) |
 Lactate, mmol/L | 2.0 (1.5–4.4) |
 C-reactive protein, mg/L | 117.7 (68.4–189.0) |
 Procalcitonin, ng/mL | 1.4 (0.3–4.3) |
Pneumothorax | 22 (18.5) |
Tracheostomy | 45 (37.8) |
28-day mortality | 45 (37.8) |